What is ALS?
Amyotrophic Lateral Sclerosis (ALS) also known as Lou Gehrig’s disease, is a neurodegenerative disease in which progressive muscle weakness leads to paralysis. ALS is a result of the death of motor neurons (nerve cells) in the brain and spinal cord that control voluntary muscle movement. Most people survive less than five years following diagnosis, but a small percentage of patients live for ten years or even longer. So far, there is no cure.
Study compares data from hundreds of people in childhood and old age
A new study shows compelling evidence that associations between cognitive ability and cortical grey matter in old age can largely be accounted for by cognitive ability in childhood. The joint study by the Montreal Neurological Institute and Hospital, The Neuro, McGill University and the University of Edinburgh, UK was published today, June 4 in
Dr. Robert J.
Research opens door to new drug therapies for Parkinson’s disease
McGill University researchers have unlocked a new door to developing drugs to slow the progression of Parkinson’s disease. Collaborating teams led by Dr. Edward A. Fon at the Montreal Neurological Institute and Hospital -The Neuro, and Dr. Kalle Gehring in the Department of Biochemistry at the Faculty of Medicine, have discovered the three-dimensional structure of the protein Parkin.
Live 3D images of brain’s vasculature will improve patient diagnosis and treatment
The diagnosis and treatment of potentially life-threatening neurological conditions such as aneurysms and strokes will be significantly improved as a result of cutting-edge technology at the Montreal Neurological Institute and Hospital - The Neuro, at McGill University and the MUHC. The new angiosuite, inaugurated today, offers significant advantages to patients and physicians including most importantly, improved safety and outcomes.
- Creates a 3D “
New study shows what happens in the brain to make music rewarding
A new study reveals what happens in our brain when we decide to purchase a piece of music when we hear it for the first time. The study, conducted at the Montreal Neurological Institute and Hospital – The Neuro, McGill University and published in the journal Science on April 12, pinpoints the specific brain activity that makes new music rewarding and predicts the decision to purchase music.
What is Parkinson’s Disease?
Parkinson’s disease is a neurological condition related to the death of specific brain cells that produce dopamine, a chemical needed for brain cells to control muscular movement. In Parkinson’s disease, dopamine-producing cells stop functioning for reasons still unknown.
Powerful treatment improves patients’ lives and provides new insight into mechanisms of the disease
A new study by Multiple Sclerosis researchers at three leading Canadian centres addresses why bone marrow transplantation (BMT) has positive results in patients with particularly aggressive forms of MS. The transplantation treatment, which is performed as part of a clinical trial and carries potentially serious risks, virtually stops all new relapsing activity as observed upon clinical examination and brain MRI scans. The study reveals how th
A team of basic and clinical scientists led by the University of Montreal Hospital* Research Centre’s (CRCHUM) Dr. Nathalie Arbour has opened the door to significantly improved treatments for the symptoms of Multiple Sclerosis (MS).
March - National Epilepsy Awareness Month
The Neuro has been at the forefront of epilepsy treatment and research for over half a century. The development of “The Montreal Procedure” by Dr.